Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.

Chouchi M, Kaabachi W, Klaa H, Tizaoui K, Turki IB, Hila L.

BMC Neurol. 2017 Feb 15;17(1):32. doi: 10.1186/s12883-017-0801-x.

2.

Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.

Roth AD, Lee MY.

Biomed Res Int. 2017;2017:9176937. doi: 10.1155/2017/9176937. Epub 2017 Jan 4. Review.

3.

Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.

Kamani MA, Provençal P, Boutin M, Pacienza N, Fan X, Novak A, Huang TC, Binnington B, Au BC, Auray-Blais C, Lingwood CA, Medin JA.

Future Sci OA. 2016 Oct 13;2(4):FSO147. doi: 10.4155/fsoa-2016-0027. eCollection 2016 Oct 13.

4.
5.

Intracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing).

Kigen G, Edwards G.

BMC Pharmacol Toxicol. 2016 Aug 14;17(1):37. doi: 10.1186/s40360-016-0079-4.

6.

CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT/GSK-3β/Snail Signals.

Lu LL, Chen XH, Zhang G, Liu ZC, Wu N, Wang H, Qi YF, Wang HS, Cai SH, Du J.

Oxid Med Cell Longev. 2016;2016:5874127. doi: 10.1155/2016/5874127. Epub 2015 Dec 28.

7.

Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.

Xie JD, Huang Y, Chen DT, Pan JH, Bi BT, Feng KY, Huang W, Zeng WA.

PLoS One. 2015 Dec 3;10(12):e0143701. doi: 10.1371/journal.pone.0143701. eCollection 2015 Dec 3.

8.

Frog intestinal perfusion to evaluate drug permeability: application to p-gp and cyp3a4 substrates.

Yerasi N, Vurimindi H, Devarakonda K.

Front Pharmacol. 2015 Jul 14;6:141. doi: 10.3389/fphar.2015.00141. eCollection 2015 Jul 14.

9.

Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers.

Anand P, O'Neil A, Lin E, Douglas T, Holford M.

Sci Rep. 2015 Aug 3;5:12497. doi: 10.1038/srep12497.

10.

Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.

Walsh DR, Nolin TD, Friedman PA.

Pharmacol Rev. 2015 Jul;67(3):656-80. doi: 10.1124/pr.115.010728. Review.

11.

Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.

Bello I, Salerno M.

Cell Stress Chaperones. 2015 May;20(3):421-30. doi: 10.1007/s12192-014-0566-8. Epub 2015 Jan 16.

12.

Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier.

Liu JS, Wang JH, Zhou J, Tang XH, Xu L, Shen T, Wu XY, Hong Z.

Int J Nanomedicine. 2014 Aug 16;9:3923-35. doi: 10.2147/IJN.S62263. eCollection 2014 Aug 16.

13.

Multilayer spheroids to quantify drug uptake and diffusion in 3D.

Achilli TM, McCalla S, Meyer J, Tripathi A, Morgan JR.

Mol Pharm. 2014 Jul 7;11(7):2071-81. doi: 10.1021/mp500002y. Epub 2014 Apr 2.

14.

Identification of p-glycoprotein and transport mechanism of Paclitaxel in syncytiotrophoblast cells.

Lee NY, Lee HE, Kang YS.

Biomol Ther (Seoul). 2014 Jan;22(1):68-72. doi: 10.4062/biomolther.2013.105.

15.

Molecular cloning and characterization of a P-glycoprotein from the diamondback moth, Plutella xylostella (Lepidoptera: Plutellidae).

Tian L, Yang J, Hou W, Xu B, Xie W, Wang S, Zhang Y, Zhou X, Wu Q.

Int J Mol Sci. 2013 Nov 20;14(11):22891-905. doi: 10.3390/ijms141122891.

16.

Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate.

Vilas-Boas V, Silva R, Palmeira A, Sousa E, Ferreira LM, Branco PS, Carvalho F, Bastos Mde L, Remião F.

PLoS One. 2013 Aug 26;8(8):e74425. doi: 10.1371/journal.pone.0074425. eCollection 2013 Aug 26.

17.

Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital.

Subenthiran S, Abdullah NR, Joseph JP, Muniandy PK, Mok BT, Kee CC, Ismail Z, Mohamed Z.

PLoS One. 2013 May 23;8(5):e64827. doi: 10.1371/journal.pone.0064827. Print 2013.

18.

The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia.

Nestal de Moraes G, Souza PS, Costas FC, Vasconcelos FC, Reis FR, Maia RC.

Leuk Res Treatment. 2012;2012:671702. doi: 10.1155/2012/671702. Epub 2012 Apr 24.

19.

Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene.

van Assema DM, Lubberink M, Rizzu P, van Swieten JC, Schuit RC, Eriksson J, Scheltens P, Koepp M, Lammertsma AA, van Berckel BN.

EJNMMI Res. 2012 Oct 16;2(1):57. doi: 10.1186/2191-219X-2-57.

20.

The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.

Dulin JN, Moore ML, Grill RJ.

J Neurotrauma. 2013 Feb 1;30(3):211-26. doi: 10.1089/neu.2012.2587. Epub 2013 Jan 23.

Supplemental Content

Support Center